使用Epiprotect®与Biobrane®治疗儿童部分厚度烧伤的急性愈合结局:一项回顾性比较研究
该回顾性研究比较了Epiprotect®与Biobrane®在儿童部分厚度烧伤中的急性愈合结局,共纳入99例患者(Epiprotect®组38例,Biobrane®组61例)。两组完全愈合时间中位数分别为19.5天与16天(P=0.14),住院时长均为2天(P=0.85),Epiprotect®组感染率显著更低(2.6% vs 16.4%,P=0.048),依从率无差异,再手术率均为13.2%(P>0.99)。作者认为Epiprotect®是Biobrane®的可行替代方案,但需进一步前瞻性随机研究。
要点
- Epiprotect®组感染率2.6%,Biobrane®组16.4%,差异有统计学意义(P=0.048)。
- 两组完全愈合时间中位数19.5天 vs 16天(P=0.14),住院时长均为2天(P=0.85)。
- 依从率无差异,再手术率均为13.2%(P>0.99),术后抗生素未影响依从和感染率。
核心结论
- Epiprotect®在儿童部分厚度烧伤中的急性愈合结局与Biobrane®相当,且感染率显著更低。
- 作者认为Epiprotect®是Biobrane®的可行替代方案,但需进一步前瞻性随机研究探究短期和长期结局。
研究设计与样本
- 回顾性比较研究,纳入5年期间在本烧伤中心使用Biobrane®或Epiprotect®治疗的年龄<18岁部分厚度烧伤患儿。
- 共纳入99例患者,其中Epiprotect®组38例,Biobrane®组61例。
- 总烧伤面积均值6%(范围1%-15%),年龄中位数21个月(范围5-169个月)。
主要发现
- Epiprotect®组完全愈合时间中位数19.5天,Biobrane®组16天(P=0.14)。
- 两组住院时长中位数均为2天(P=0.85)。
- Epiprotect®组感染率2.6%,Biobrane®组16.4%(P=0.048)。
- 两组依从率无差异;再手术率均为13.2%(P>0.99)。
- 按深度亚组分析时上述趋势保持一致;术后抗生素未影响两组依从率(P>0.99)和感染率(P=0.65)。
临床怎么用
- 作者认为Epiprotect®是儿童部分厚度烧伤中Biobrane®的可行替代方案。
- 作者指出仍需进一步前瞻性随机研究探究短期和长期结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To compare the acute healing outcomes of Biobrane® and Epiprotect® in paediatric partial thickness (PT) burns. METHODS: All paediatric patients (age <18 years) with PT burns managed using either Biobrane® or Epiprotect® over a 5-year period at our burns unit were included. The primary outcome was time to complete healing. Secondary outcomes included adherence, infection rates, length of hospital stay, duration of acute follow-up and return to the theatre. RESULTS: Among the 99 patients included, 38 received Epiprotect® and 61 received Biobrane®. The mean total body surface area (TBSA) was 6% (range 1%-15%) and median age was 21 months (range 5-169 months). Median time to healing in the Epiprotect® group was 19.5 days and 16 days in the Biobrane® group (P = .14). The median hospitalisation length was the same for both products (2 days, P = .85). Infection rate was lower in the Epiprotect® group (2.6% vs 16.4%, P = .048). There was no difference in adherence rate. These trends were preserved when depth sub-groups were analysed. Adherence and infection rates were not affected by post-operative antibiotics (P > .99 and P = .65, respectively) in either group. The rate of return to the theatre for further surgery was 13.2% for both products (P > .99). CONCLUSION: Our findings demonstrate that acute healing outcomes with Epiprotect® in paediatric PT burns are comparable to those with Biobrane®, with significantly lower infection rates for Epiprotect®. These results suggest that Epiprotect® is a viable alternative to Biobrane®. Nevertheless, further prospective randomised studies are required to investigate the short- and long-term outcomes.
引用
- Khamise A, Lapid H, Mishra A, et al. Acute healing outcomes in paediatric partial thickness burns using Epiprotect® and Biobrane®: A retrospective comparative study. J Plast Reconstr Aesthet Surg. 2024. PMID: 38875874. doi:10.1016/j.bjps.2024.05.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。